Russia’s invasion a year ago has exacerbated the problems that afflicted Ukraine’s health care system, creating a new threat to the lives of patients struggling with cancer.
In 1991, Ukraine started to transform its healthcare system, and these changes continue to this day.
By Robert A. Winn, MDDirector and Lipman Chair in Oncology, VCU Massey Cancer Center,Senior associate dean for cancer innovation, VCU School of Medicine,Professor, Division of Pulmonary Disease and Critical Care Medicine,Virginia Commonwealth University;Guest editor, The Cancer History ProjectAsk members of the oncology community about the Howard University Cancer Center (HUCC), and more than 70 years later they will more than likely mention the man who laid the foundation for it.
On March 7, join Stacy Wentworth, Mirelle Luecke, and Karen Tumulty, in a free virtual panel discussion about Betty Ford and Nancy Reagan—two First Ladies who made history when they were diagnosed with breast cancer while in the White House.
The following is an excerpt from How We Do Harm: A Doctor Breaks Ranks About Being Sick in America, by Otis W. Brawley, MD, with Paul Goldberg, published in 2012.
On May 25, 2020, George Floyd said “I can’t breathe” more than 20 times before he suffocated on a street in Minneapolis. On Jan. 7, 2023, Tyre Nichols repeatedly screamed, “Mom, mom, mom” as he was beaten to death on a street in Memphis.
Richard Silvera is working to build trust between doctors Bronx communities that have a heavy burden of anal cancer.
Nearly three years ago, Robert A. Winn and Otis Brawley provided their unforgettable personal perspectives on the murder of George Floyd by Minneapolis police.
The release of FDA’s draft guidance, “Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases,” has been greatly anticipated since June 2021, when FDA announced in its accelerated approval of the KRASG12C inhibitor sotorasib that it would require a randomized, controlled trial comparing the efficacy of the labeled dose (960 mg once daily) to a 75% lower dose (240 mg once daily) as a condition of full regulatory approval (The Cancer Letter, June 11, 2021; April 29, 2022).
Duke Cancer Institute is commemorating 50 years of gynecologic care and research.
